Topics

Articles

The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.

PharmaCord, Mercalis Merge in an Effort to Support the Patient Journey

The injection for the treatment of psoriatic arthritis—among other indications—is a biosimilar to Stelara. 

Selardsi Launches in the US Market

Videos

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the challenges associated with meeting the FDA’s 2025 CGT forecasted approval goal. 

Tackling Gaps in Manufacturing, Funding, and Expertise

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea

The acquisition features Caplyta as part of its neuroscience portfolio, which is considered the only FDA-approved treatment for bipolar I and II depression as a monotherapy and adjunctive treatment.

J&J Inks $14.6 Billion Intra-Cellular Therapies Deal

A session provides considerations for manufacturers during development, rollouts, and implementation, specifically as it pertains to the HSSP perspective.  

Trade & Channel Strategies 2024: Lessons Learned and Considerations with Humira

Access Insights Conference delves into the latest obstacles,   while mapping out potential solutions to address them. 

Conference Connect: Tackling the Issues that Matter in the Access Space

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Dr. Reddy’s immuno-oncology drug for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma will be marketed under the brand name Zytorvi.

Toripalimab Launches in India

The agreement provides PTC with $1 billion in cash once deal closes, and is centered around PTC518's development, manufacturing and commercialization.

Commercial Channels